Dr. Bracha has global biotechnology experience, working at companies of various sizes and stages of development. Throughout her career, Dr. Bracha has been committed to advancing innovation and the development of novel therapies for patients. She is currently the President of Edity Therapeutics, prior to that she served as Senior Vice President of Corporate Strategy and Business Development at Clover Biopharmaceuticals. Abigail also held leadership positions at Rubius Therapeutics where she led corporate development. Earlier in her career, Abigail worked in corporate venture capital at GE Ventures and founded the global technology scouting team for GE Healthcare Life Sciences, where she built and led the Search and Evaluation team. She also worked in the technology sector at Amazon Web Services and Dell-EMC. Abigail completed her PhD from Harvard University in Experimental Pathology and was a National Science Foundation Graduate Research Fellow.